Abstract:The nonselective membrane disruption of antimicrobial peptides (AMPs) helps in combating the antibacterial resistance. But their overall positive charges lead to undesirable hemolysis and toxicity toward normal living cells, as well as the rapid clearance from blood circulation. In consequence, developing smart AMPs to optimize the antimicrobial outcomes is highly urgent. Relying on the local acidity of microbial infection sites, in this work, we designed an acidity-triggered charge reversal nanotherapeutics with adaptable geometrical morphology for bacterial targeting and optimized therapy. C 16 -A 3 K 4 -CONH 2 was proposed and the ε-amino groups in lysine residues were acylated by dimethylmaleic amide (DMA), enabling the generated C 16 -A 3 K 4 (DMA)-CONH 2 to self-assemble into negatively charged spherical nanostructure, which relieved the protein adsorption and prolonged blood circulation in vivo . After the access of C 16 -A 3 K 4 (DMA)-CONH 2 into the microbial infection sites, acid-sensitive β-carboxylic amide would hydrolyze to regenerate the positive C 16 -A 3 K 4 -CONH 2 to destabilize the negatively charged bacterial membrane. In the meanwhile, attractively, the self-assembled spherical nanoparticle transformed to rod-like nanostructure, which was in favor of the efficient binding with bacterial membranes due to the larger contact area. Our results showed that the acid-activated AMP nanotherapeutics exhibited strong and broad-spectrum antimicrobial activities against Yeast, Gram-positive Staphylococcus aureus , Gram-negative Escherichia coli , and methicillin-resistant Staphylococcus aureus (MRSA). Moreover, the biocompatible lipopeptide nanotherapeutics dramatically improved the dermapostasis caused by bacterial infection. The strategy of merging pathology-activated therapeutic function and morphological adaptation to augment therapeutic outcomes shows the great potential for bacterial inhibition. Statement of significance The overall positive charges of antimicrobial peptides (AMPs) lead to undesirable hemolysis and nonselective toxicity, as well as the rapid clearance from blood circulation. Infection-activated lipopeptide nanotherapeutics with adaptable geometrical morphology were developed to address these issues. The self-assembled lipopeptide was pre-decorated to reverse the positive charge to reduce the hemolysis and nonselective cytotoxicity. After accessing the acidic infection sites, the nanotherapeutics recovered the positive charge to destabilize negatively charged bacterial membranes. Meanwhile, the morphology of self-assembled nanotherapeutics transformed from spherical nanoparticles to rod-like nanostructures in the lesion site, facilitating the improved association with bacterial membranes to boost the therapeutic efficiency. These results provide new design rationale for AMPs developed for bacterial inhibition.

Intramembrane Nanoaggregates of Antimicrobial Peptides Play a Vital Role in Bacterial Killing

Structural Disruptions of the Outer Membranes of Gram-Negative Bacteria by Rationally Designed Amphiphilic Antimicrobial Peptides.

How do antimicrobial peptides disrupt the lipopolysaccharide membrane leaflet of Gram-negative bacteria?

Molecular Mechanism of Intracellular Killing Effect of Antimicrobial Peptides on Microbes

Unlocking roles of cationic and aromatic residues in peptide amphiphiles in treating drug-resistant gram-positive pathogens

Structural elucidation upon binding of antimicrobial peptides into binary mixed lipid monolayers mimicking bacterial membranes

Antimicrobial Peptide Mechanism Studied by Scattering-Guided Molecular Dynamics Simulation

Antimicrobial Properties And Membrane-Active Mechanism Of A Potential Alpha-Helical Antimicrobial Derived From Cathelicidin Pmap-36

Theoretical Insight into the Relationship Between the Structures of Antimicrobial Peptides and Their Actions on Bacterial Membranes.

Novel non-helical antimicrobial peptides insert into and fuse lipid model membranes

Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities

How do Self-Assembling Antimicrobial Lipopeptides Kill Bacteria?

How the Antimicrobial Peptides Kill Bacteria: Computational Physics Insights

Unveiling mechanisms of antimicrobial peptide: Actions beyond the membranes disruption

How Melittin Inserts into Cell Membrane: Conformational Changes, Inter-Peptide Cooperation, and Disturbance on the Membrane

Implications of Lipid Monolayer Charge Characteristics on Their Selective Interactions with a Short Antimicrobial Peptide

Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity.

Structural Contributions to the Intracellular Targeting Strategies of Antimicrobial Peptides

The Antimicrobial Peptide 1018-K6 Interacts Distinctly with Eukaryotic and Bacterial Membranes, the Basis of Its Specificity and Bactericidal Activity

Relationship Between Peptide Structure and Antimicrobial Activity As Studied by De Novo Designed Peptides.

Infection-activated lipopeptide nanotherapeutics with adaptable geometrical morphology for in vivo bacterial ablation